0002020048-26-000004.txt : 20260320 0002020048-26-000004.hdr.sgml : 20260320 20260319192853 ACCESSION NUMBER: 0002020048-26-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260320 DATE AS OF CHANGE: 20260319 EFFECTIVENESS DATE: 20260320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Averna Therapeutics Inc. CENTRAL INDEX KEY: 0002020048 ORGANIZATION NAME: EIN: 880954191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-510828 FILM NUMBER: 26775721 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVENUE CITY: WATERTOWN STATE: MA ZIP: 10022 BUSINESS PHONE: 972 73 2822600 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVENUE CITY: WATERTOWN STATE: MA ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Exsilio Therapeutics Inc. DATE OF NAME CHANGE: 20240416 D/A 1 primary_doc.xml X0708 D/A LIVE 0002020048 Averna Therapeutics Inc. 134 COOLIDGE AVENUE WATERTOWN MA MASSACHUSETTS 10022 972 73 2822600 DELAWARE None Exsilio Therapeutics Inc. Corporation true 2022 Thomas Barnes Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Executive Officer Chief Executive Officer/President Richard Morris Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Executive Officer Chief Financial Officer Tal Zaks Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Executive Officer Roy Amariglio Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Stephen Squinto Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Raju Prasad Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Michal Silverberg Averna Therapeutics 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Nick Olsen Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Henry Chen Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Dylan Morris Averna Therapeutics Inc. 134 COOLIDGE AVENUE Watertown MA MASSACHUSETTS 10022 Director Other Health Care Decline to Disclose 06b true 0000911420-25-000115 2024-04-08 false true true true true Series A Convertible Preferred Stock, including underlying common shares ("Convertible Security Shares") false 0 85000000 84999995 5 Total sales includes dollar value of converted SAFEs. false 13 0 0 0 true Averna Therapeutics Inc. /s/ Thomas Barnes Thomas Barnes Chief Executive Officer/President 2026-03-19